News

Akari Therapeutics plc announced that it is continuing key research on its antibody-drug conjugate (ADC) payload PH1 to ...
Pioneer in RNA research who gave children with SMA a future Sabine Löwer Communications Boehringer Ingelheim St ...
What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have ...
New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...
Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, ...
One chemistry tweak made mRNA vaccines dramatically safer and more effective—unlocking new potential for fighting disease.
A fed-batch reaction is harder to design than a batch process because of the need to specify all the variables and quantities.
Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...
RNA Victoria funds 2 Florey projects to prevent and treat Alzheimer's diseaseKey points mRNA Victoria has funded 2 Alzheimer's disease research ...
The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV ...